Home
Register Now Thursday, May 23, 2024 Time: 11:30 – 12:15 pm ET / 5:30 – 6:15 pm CET CME | CNE | CPE Virtual The therapeutic landscape for treating relapsed/refractory chronic lymphocytic leukemia (R/R CLL) is rapidly evolving, with numerous trials and approvals leading to the availability of multiple treatment options. Though this range of therapies enables the individualization of treatment for patients, it also creates a need to establish optimal treatment sequencing. In this live virtual event, experts